InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Joshi Abhay, Chief Executive Officer. Director active across 1 company, notably Revance Therapeutics, Inc.. Aggregated, 3 filings have been published. Activity tracked since 15 February 2022. The latest transaction was disclosed on 15 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
2,607 shares@ US$15.7942.5% of flowCommon StockSEC:0001209191-22-019727:0
2,151 shares@ US$13.3528.7% of flowCommon StockSEC:0001479290-22-000023:0
2,151 shares@ US$13.35100.0% of flowCommon StockSEC:0001479290-22-000023
3 of 3 declarations
About Joshi Abhay
Abhay Joshi is the Chief Executive Officer, President, and Head of R&D at Revance Therapeutics, Inc. In this role, he oversees the operations and research and development strategy of the company. Abhay is committed to promoting innovation and enhancing the treatments offered by Revance.
